<< Sunday | Posters Home | Tuesday>>

	indicates a poster featured in a Poster Tour ( ticketed session with limited registration)
		Sunday, May 17, 2015, 11:00 – 11:45 AM: Esophagus & Gastric (non-CME) Monday, May 18, 2015, 11:00 – 11:45 AM: HPB (non-CME)
	indicates a Poster of Distinction.

Monday, May 18, 2015
Basic: Colon-Rectal
Mo1887	Three Protein Combinations Angiogenin, Galectin-3 and Activin-A Improves Sensitivity and Specificity of Plasma Analysis for Colorectal Cancer Detection H m C. Shantha Kumara, Surgery, St Lukes Roosevelt Hospital Center, New York, NY
Basic: Hepatobiliary
Mo1888	Inhibition of Mast Cells Degranulation Protects Liver from LPS Induced Inflammation through Hypothalamic - Pituitary - Thyroid Axis Xiqiao Zhou, Gastroenterology, The first Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu China
Basic: Pancreas
Mo1889	Different Characteristics in Hormonal Expression between Primary Pancreatic Neuroendocrine Tumors (PNETs) and Metastatic Sites Hideyo Kimura, Department of Surgery and Oncology Graduate School of Medical Sciences Kyushu University, Fukuoka-city Japan
Basic: Stomach
Mo1890	Elevation of Bile Acids after Bariatric Surgery May Attenuate Early Atherosclerosis Raymond G. Lau, Department of Bariatric Surgery, Winthrop University Hospital, East Northport, NY
Clinical: Colon-Rectal
Mo1619	Postoperative C-Reactive Protein Measurement Predicts the Severity of Complications following Surgery for Colorectal Cancer Stephen Thomas McSorley, Academic Unit of Surgery, University of Glasgow, Glasgow United Kingdom
Mo1620	The Effect of Fecal Diversion on Infectious Complications following Low Colorectal Surgery Ahmad Ibrahim Elnahas, General Surgery, University of Toronto, Toronto, ON Canada
Mo1621	The Impact of Adhesiolysis during Elective Abdominal Surgery on Quality of Life Chema Strik, Abdominal Surgery, Radboud University Medical Center, Nijmegen, Gelderland Netherlands
Mo1622	The Presence of Abdominal Hernia Is Associated with Adverse Outcomes of the Ileal Pouch Ganglei Liu, Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH
Mo1623	A Retrospective Study of 45 Patients Who Underwent Surgical Treatment for Local Recurrence of Rectal Cancer Hideaki Karasawa, Department of Surgery, Tohoku University Hospital, Sendai, Miyagi Japan
Mo1624	Comparative Analysis of Single Incision Colorectal Surgery in Obese and Non-Obese Patients: A Case-Matched Study Jean-Paul Joseph LeFave,, Surgery, Colorectal Surgical Associates, University of Texas Medical School at Houston, Houston, TX
Mo1625	Outcomes and Predictors of Mortality in Surgical Treatment for Clostridium Difficile Colitis in a High Volume Center Emre Gorgun, Colorectal Surgery, Cleveland Clinic, Cleveland, OH
Mo1626	Is There a Relationship between Body Composition and Blood Micronutrient Concentrations in Male and Female Patients with Operable Colorectal Cancer? Paul G. Horgan, Academic Unit of Surgery, University of Glasgow, Glasgow United Kingdom
Mo1627	Predictive Factors and Outcomes of Unplanned Readmissions in a High-Volume Colorectal Unit Cigdem Benlice, Cleveland Clinic, Cleveland, OH
Mo1628	One-Stage Colectomy with Intraoperative Colonic Irrigation for Acute Left-Sided Malignant Colonic Obstruction Shimpei Otsuka, Surgery, Ogaki Municipal Hospital, Ogaki, Gifu Japan
Mo1629	Abdominal Adhesions and Pain Six Months after Elective Abdominal Surgery: A Prospective Analysis Chema Strik, Abdominal Surgery, Radboud University Medical Center, Nijmegen, Gelderland Netherlands
Mo1630	Length of Bowel Distal to a Diverting Ileostomy (DI) Does Not Influence the Risk of Dehydration after Ileal Pouch-Anal Anastomosis (IPAA) Sharon Z. Koh, Surgery, Cedars Sinai Medical Center, West Hollywood, CA
Mo1631	Can a Diverting Ileostomy Be Safely Closed in Patients with an Asymptomatic Radiologic Leak after Pelvic Bowel Anastomosis? Sharon Z. Koh, Surgery, Cedars Sinai Medical Center, West Hollywood, CA
Mo1632	Readmission following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis: Can We Predict (or Avoid) Them? Alexander Stephen Martin, Department of Surgical Oncology, University of Cincinnati, Cincinnati, OH
Clinical: Esophageal
Mo1633	Sarcopenia Does Not Impact Morbidity or Survival in Patients with Resectable Esophageal Adenocarcinoma G Paul Wright, GRMEP/Michigan State University, Grand Rapids, MI
Mo1634	Rural Disparities in Esophageal Cancer Outcomes Based on Distance from Endoscopic Ultrasound (EUS)-Trained Gastroenterologists James Regan, Surgery, Southern Illinois University School of Medicine, Springfield, IL
Mo1635	Lymph-Node Dissection along the Left Recurrent Laryngeal Nerve after Esophageal Stripping in VATS-E (Video-Assisted Thoracoscopic Surgery of Esophagus) and Safe Anastomotic Technique Hiroshi Makino, Surgery, Nippon Medical School, Tama Nagayama Hospital, Tokyo Japan
Mo1636	The Requirement of Lymphadenectomy for Esophageal Carcinoma: Harvesting Least Lymph Node Stations Is More Applicable Long-Qi Chen, Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan China
Mo1637	Extent of Lymph Node Involvement after Esophagectomy with Extended Lymphadenectomy for Esophageal Adenocarcinoma Predicts Recurrence: A Large North American Cohort Study Sara Najmeh, Surgery, McGill University, Montreal, QC Canada
Mo1638	Dysphagia after Nissen Fundoplication: Is Preoperative Esophageal Motility a Factor? Anna Aronova, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
Mo1639	Quantitative Assessment of Esophageal Emptying in Achalasia Patients Using Esophageal Transit Scintigraphy Joshua A. Boys, Surgery, Univ. of Southern California, Los Angeles, CA
Mo1640	One-Year Outcomes of Laparoscopic Paraesophageal Hernia Repair Stratified by Hernia Size Daniel Davila, General Surgery, Medical College of Wisconsin, Milwaukee, WI
Mo1641	Complete Pathologic Response Is an Independent Predictor of Improved Survival following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma Raed M. Alnaji, Department of Internal Medicine, University at Buffalo, Buffalo, NY
Mo1642	Is Minimally Invasive Esophagectomy Oncologically Safe? Results of a Case-Control Study Marisa Aral, General Surgery Department, Centro Hospitalar de São João, University of Porto Medical School, Porto Portugal
Mo1643	Early Postoperative Outcomes of Magnetic Gastroesophageal Junction Reinforcement Compared to Laparoscopic Nissen Fundoplication Matthew Robert Pittman, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, OH
Clinical: Hepatobiliary
Mo1644	Technical Feasibility of Confocal Laser Endomicroscopy in Laparoscopic Surgery: The PERSEE Project Brice Gayet, Department of Digestive diseases, Institut Mutualiste Montsouris, Paris France
Mo1645	Retrospective Review of Clinical Outcomes in Undetectable Mass of the Pancreatic Head Prior to Pancreatoduodenectomy Hideo Takahashi, general surgery, Cleveland Clinic, Cleveland, OH
Mo1646	Impact of Intratumoral Nerve Growth Factor Expression on Perineural Invasion and Prognosis in Resectable Extrahepatic Cholangiocarcinoma Kazuhide Urabe, Department of Surgery, Applied Life Sciences Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima-city, Hiroshima Pref Japan
Mo1647	Outcomes from the Swedish Registry of Gallstone Surgery and ERCP (GallRiks): Clinical Consequences and Implementation during a 10-Year Period Lars Enochsson, Department of Surgical Gastroenterology, Division of surgery, CLINTEC, Karolinska Institutet, Stockholm Sweden
Mo1648	Outcomes of Surgeon-Performed Endoscopic Retrograde Cholangiopancreatography Edward L. Jones, Surgery, The Ohio State University, Columbus, OH
Mo1649	Impact of Laparoscopic Splenectomy for Hypersplenism in Cirrhotic Patients on Long-Term Liver Function Naoki Yamamoto, Gastroenterological surgery, Kagawa University, Kitagun, Kagawa Japan
Mo1650	Readmission after Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis Gaya Spolverato, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
Mo1651	Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma Hishaam Ismael, Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
Mo1652	Predicting the Need for Dependent Care in Geriatric Patients after Emergency Cholecystectomy Yaser M. K. Baghdadi, Department of Surgery, Division of Trauma, Critical Care and General Surgery, Mayo Clinic, Rochester, MN
Clinical: Other
Mo1652a	Mortality and Adverse Outcomes in Elderly Patients Undergoing Major Gastrointestinal Cancer Surgery Paul RA O'Mahoney, Surgery, NewYork Presbyterian-Weill Cornell Medical Center, New York, NY
Mo1652b	The Need for Perioperative Transfusion Guidelines: Significant Surgeon and Hospital Variation in Blood Transfusion Utilization following Upper Gastrointestinal Cancer Resection Christopher Thomas Aquina, Surgery, University of Rochester, Rochester, NY
Clinical: Pancreas
Mo1653	Serum Carbohydrate Antigen 19-9 Values after Neoadjuvant Therapy Predict Survival of Patients with Pancreatic Adenocarcinoma: A Multicenter Case-Control Study of 269 Patients Shuichi Aoki, Department of Surgery, Tohoku University Graduate School of Medicine, Sendai-city Japan
Mo1654	Malignant Progression in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Outcome of Initially Selected for Resection or Primary Surveillance Takuya Sakoda, Department of Surgery, Applied Life Sciences Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima Japan
Mo1655	Has Survival following Pancreaticoduodenectomy for Pancreas Adenocarcinoma Improved over Time? AHMED I. SALEM, General Surgery, University of Wisconsin, Madison, WI
Mo1656	Pancreatic Cancer Patients with Lymph Node Involvement by Direct Tumor Extension Have Similar Survival to Those with Node-Negative Disease Jennifer Lynn Williams, Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA
Mo1657	Prognostic Value of the Systemic Inflammatory Response Syndrome (SIRS), BISAP Scale and HAPS in Patients with Acute Pancreatitis Antonio Ramos, Hospital Español, Veracruz Mexico
Mo1658	Prognostic Impact of Para-Aortic Lymph Node Micrometastasis in Pancreatic Ductal Adenocarcinoma Toshiaki Komo, Department of Surgery, Applied Life Sciences institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Hiroshima Japan
Mo1659	Neutrophil to Lymphocyte Ratio Correlates with Pre-Operative Ca 19-9 and Predicts Overall Survival in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma Antonio Masi, Surgery, NYU School of Medicine, New York, NY
Mo1660	Neoadjuvant Therapy Followed by Surgical Resection for Borderline Resectable Pancreatic Cancer with Artery Involvement Hiroki Yamaue, Second Department of Surgery, Wakayama Medical University School of Medicine, Wakayama Japan
Mo1661	Does the Pancreatic Resection Have Any Survival Benefit in Patients with a Pancreatic Adenocarcinoma and Intraoperatively Diagnosed Positive Para-Aortic Lymph Node Metastasis or Peritoneal Lavage Cytology? Hironobu Suto, National Cancer Center Hospital, Tokyo Japan
Mo1662	Modified Appleby Procedure with Arterial Reconstruction: A Literature Review and Report of 3 Unusual Cases Jessica A Latona, Surgery, Thomas Jefferson University Hospital, Philadelphia, PA
Mo1663	Spleen Preserving Distal Pancreatectomy (SPDP): Does Splenic Vessel Preservation (SVP) Have Better Postoperative Outcomes: A Systematic Review and Meta-Analysis Fady Elabbasy, Surgical Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Mo1664	Surgical Management of Severely Inflamed Chronic Pancreatitis with Total Pancreatectomy Followed by Islet Autotransplantation Rauf Shahbazov, Islet Cell Laboratory, Baylor Research Institute, Dallas, TX
Mo1665	Pancreaticogastrostomy following Pancreaticoduodenectomy Is Associated with Low Re-Operation and Pancreatic Fistula Rates Jennifer K. Plichta, Department of Surgery, Loyola University Medical Center, Maywood, IL
Mo1666	Pancreatic Surgery for Pancreatic Adenocarcinoma: A Comparison between the Laparoscopic and Open Surgical Approach John Stauffer, Mayo Clinic, Jacksonville, FL
Mo1667	Central Pancreatectomy for Benign or Low-Grade Malignant Tumors: A Single Center Experience Elizabeth A. Paulus, Surgical Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Mo1668	Practice Patterns and Impact of Imaging Surveillance after Resection for Pancreatic Ductal Adenocarcinoma June Peng, Cleveland Clinic, Cleveland, OH
Clinical: Small Bowel
Mo1669	Double Balloon Enteroscopy Is a Safe and Effective Technique for Retrieval of Entrapped Foreign Body in the Small Bowel for Greater than 100 Days Wei-Chung Chen, Gastroenterology, Mayo Clinic Florida, Jacksonville, FL
Mo1670	The Role of Surgery in Crohn's Disease: Single Center Experience from 2005-2014 Florian Kuehn, Dept. of General, Thoracic, Vascular and Transplantation Surgery, University of Rostock, Rostock Germany
Mo1671	Trends in Non-Traumatic Abdominal Compartment Syndrome John Afthinos, Staten Island University Hospital, Bayside, NY
Mo1672	Candy Cane Roux Syndrome: An Under Recognized Complication of an Excessive Roux Limb after Roux-en-Y Gastric Bypass Surgery Abdul Rehman, Internal Medicine Gastroenterology, Georgia Regents University, Augusta, GA
Clinical: Stomach
Mo1673	Outcomes after Completion Total Gastrectomy for Gastric Remnant Cancer Etienne St-Louis, General Surgery, McGill University, Montreal, QC Canada
Mo1674	Treatment Modalities for Delayed Gastric Emptying following Esophagectomy Francis Joseph DeAsis, Surgery, NorthShore University HealthSystem, Arlington Heights, IL
Mo1675	Race and Gastric Cancer Outcomes: Not Black and White Mariam F. Eskander, Surgery, Beth Israel Deaconess Medical Center, Boston, MA
Mo1676	Hospital-Volume Effect onto the Early Postoperative and Long-Term Oncological Outcome in the Surgical Management of Gastric Cancer Meyer Frank, Dept. of General, Abdominal & Vascular Surgery, University Hospital, Magdeburg Germany
Mo1677	Isolated Corrosive Gastric Strictures: New Working Classification and Management Strategies Kanagavel Manickavasagam, Dr, Dept of General, GI and Minimal Access Surgery, St Isabel Hospital, Chennai India
Mo1678	30-Day Readmission after Laparoscopic Sleeve Gastrectomy: A Predictable Event? Monica Sethi, Department of Surgery, NYU School of Medicine, New York, NY
Mo1679	Do Complications Affect Weight Loss following Sleeve Gastrectomy Tara Mokhtari, Surgery, Stanford University, Stanford, CA
Translational: Hepatobiliary
Mo2053	Hepatic Application of Ablative Thermal Energy Promotes Pro-Tumorigenic Alternative Activation of Peritoneal Macrophages via Hypoxia Inducible Factor-1? Jeniann Yi, Department of Surgery, University of Colorado, Aurora, CO
Translational: Pancreas
Mo2054	Gemcitabine Induces Major Histocompatibility Complex Class I-Related Chain A/B Expression, Activating γδ T Cell Function in Pancreatic Cancer Tomoharu Miyashita, Department of Gastroenterologic Surgery, Surgery, Kanazawa University Hospital, Johns Hopkins University School of Medicine, Kanazawa Japan